Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas.
Recent research highlights UPP1’s role in glioma progression and immune evasion. Promising target for future therapies. 🧠🔬
October 9, 2024
Follow us
latest articles
Discover the newest research about AI innovations in 🎗 Oncology.
Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma.
A recent PubMed article explores a machine learning signature for predicting outcomes in stomach adenocarcinoma. 📊🔬
October 9, 2024
Revolutionizing Cancer Treatment with AI-Driven Protein Analysis
AI-driven protein analysis transforms cancer treatment, enhancing diagnosis and drug design. Promising advancements in personalized healthcare. 🧬💡
October 6, 2024
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection.
AI algorithms may enhance early breast cancer detection, potentially improving personalized screening strategies. 📊🤖 Early detection is crucial for better outcomes.
October 4, 2024
Preoperative Prediction of Her-2 and Ki-67 Status in Gastric Cancer Using 18F-FDG PET/CT Radiomics Features of Visceral Adipose Tissue.
Recent research highlights the potential of 18F-FDG PET/CT radiomics in predicting Her-2 and Ki-67 status in gastric cancer. 📊🔍
September 30, 2024
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology.
Artificial intelligence enhances chemotherapy toxicity prediction in colorectal cancer, promoting personalized treatment strategies. 🤖💊
September 30, 2024
A virus associated with the zoonotic pathogen Plasmodium knowlesi causing human malaria is a member of a diverse and unclassified viral taxon.
A recent study reveals a novel RNA virus linked to Plasmodium knowlesi, highlighting its potential impact on malaria treatment. 🦠🩺
September 30, 2024
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients.
Recent research highlights sphingolipids, particularly sphinganine-1-phosphate, as key players in paclitaxel-induced neuropathy. 🧠💉
September 30, 2024
Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis.
New research highlights aging genes’ role in prostate cancer prognosis. A predictive model shows promise for improved outcomes. 📊🔬
September 28, 2024
Comprehensive characterization of long QT syndrome-associated genes in cancer and development of a robust prognosis model.
Long QT syndrome (LQTS) impacts cancer treatment. 🩺 A new prognostic model may enhance patient outcomes. 📊
September 25, 2024